Enhanced osteogenic potential of mesenchymal stem cells from cortical bone: A comparative analysis

Stem Cell Research and Therapy

Volumn 6, Issue 1, 2015, Pages

  Fernandez Moure, Joseph S ^a,b   Corradetti, Bruna ^b,c   Chan, Paige ^b   Van Eps, Jeffrey L ^a,b   Janecek, Trevor ^b   Rameshwar, Pranela ^d   Weiner, Bradley K ^a   Tasciotti, Ennio ^b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Cortical bone; Hypoxia; Mesenchymal stem cells; Multipotent differentiation ability; Normoxia; Osteogenic potential

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM;

ADIPOSE TISSUE; ALP GENE; ARTICLE; BGLAP GENE; BONE DEVELOPMENT; BONE MARROW DERIVED MESENCHYMAL STEM CELL; BONE MINERAL; CELL DIFFERENTIATION; CELL LINE; COLONY FORMING UNIT; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICAL BONE; FLUORESCENCE ACTIVATED CELL SORTING; GENE; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; LAMINECTOMY; MESENCHYMAL STEM CELL; MESODERM; OSTEOBLAST; OXYGEN TENSION; PROTEIN EXPRESSION; RUNX2 GENE; SPP1 GENE; STAINING; UPREGULATION; CELL CULTURE; CELL HYPOXIA; CELL PROLIFERATION; CELL SHAPE; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY;

ALKALINE PHOSPHATASE; CELL DIFFERENTIATION; CELL HYPOXIA; CELL PROLIFERATION; CELL SHAPE; CELLS, CULTURED; HUMANS; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS;

EID: 85009909730     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/s13287-015-0193-z     Document Type: Article

References (73)

1. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-7. doi:10.1080/14653240600855905.
2. Abbott S, Mackay G, Durdy M, Solomon S, Zylberberg C. Twenty years of the International Society for Cellular Therapies: the past, present and future of cellular therapy clinical development. Cytotherapy. 2014;16(4 Suppl):S112-9. doi:10.1016/j.jcyt.2014.01.001.
3. Simmons PJ, Leavesley DI, Levesque JP, Swart BW, Haylock DN, To LB, et al. The mobilization of primitive hemopoietic progenitors into the peripheral blood. Stem Cells. 1994;12 Suppl 1:187-201; discussion -2.
4. Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation. 1968;6(2):230-47.
5. Riekstina U, Muceniece R, Cakstina I, Muiznieks I, Ancans J. Characterization of human skin-derived mesenchymal stem cell proliferation rate in different growth conditions. Cytotechnology. 2008;58(3):153-62. doi:10.1007/s10616-009-9183-2.
6. Wang Y, Zhao L, Hantash BM. Support of human adipose-derived mesenchymal stem cell multipotency by a poloxamer-octapeptide hybrid hydrogel. Biomaterials. 2010;31(19):5122-30. doi:10.1016/j.biomaterials.2010.03.007.
7. Jin HJ, Bae YK, Kim M, Kwon SJ, Jeon HB, Choi SJ, et al. Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy. Int J Mol Sci. 2013;14(9):17986-8001. doi:10.3390/ijms140917986.
8. Bieback K, Kern S, Kluter H, Eichler H. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells. 2004;22(4):625-34. doi:10.1634/stemcells. 22-4-625.
9. Gutierrez-Aguirre CH, Gomez-De-Leon A, Alatorre-Ricardo J, Cantu-Rodriguez OG, Gonzalez-Llano O, Jaime-Perez JC, et al. Allogeneic peripheral blood stem cell transplantation using reduced-intensity conditioning in an outpatient setting in ABO-incompatible patients: are survival and graft-versus-host disease different? Transfusion. 2014;54(5):1269-77. doi:10.1111/trf.12466.
10. Lovati AB, Corradetti B, Cremonesi F, Bizzaro D, Consiglio AL. Tenogenic differentiation of equine mesenchymal progenitor cells under indirect co-culture. The International journal of artificial organs. 2012;35(11):996-1005. doi:10.5301/ijao.5000129.
11. Lovati AB, Corradetti B, Lange Consiglio A, Recordati C, Bonacina E, Bizzaro, D et al. Characterization and differentiation of equine tendon-derived progenitor cells. Journal of biological regulators and homeostatic agents. 2011;25(2 Suppl):S75-84.
12. Corradetti B, Meucci A, Bizzaro D, Cremonesi F, Lange Consiglio A. Mesenchymal stem cells from amnion and amniotic fluid in the bovine. Reproduction. 2013;145(4):391-400. doi:10.1530/REP-12-0437.
13. Lange-Consiglio A, Corradetti B, Bizzaro D, Magatti M, Ressel L, Tassan S, et al. Characterization and potential applications of progenitor-like cells isolated from horse amniotic membrane. Journal of tissue engineering and regenerative medicine. 2012;6(8):622-35. doi:10.1002/term.465.
14. Rutigliano L, Corradetti B, Valentini L, Bizzaro D, Meucci A, Cremonesi F, et al. Molecular characterization and in vitro differentiation of feline progenitor-like amniotic epithelial cells. Stem cell research & therapy. 2013;4(5):133. doi:10.1186/scrt344.
15. Qiao S, Ren H, Shi Y, Liu W. Allogeneic compact bone-derived mesenchymal stem cell transplantation increases survival of mice exposed to lethal total body irradiation: a potential immunological mechanism. Chin Med J (Engl). 2014;127(3):475-82.
16. Sottile V, Halleux C, Bassilana F, Keller H, Seuwen K. Stem cell characteristics of human trabecular bone-derived cells. Bone. 2002;30(5):699-704.
17. Corradetti B, Taraballi F, Powell S, Sung D, Minardi S, Ferrari M et al. Osteoprogenitor cells from bone marrow and cortical bone: understanding how the environment affects their fate. Stem cells and development. 2014;1;24(9):1112-23. doi:10.1089/scd.2014.0351.
18. Gao X, Usas A, Tang Y, Lu A, Tan J, Schneppendahl J, et al. A comparison of bone regeneration with human mesenchymal stem cells and muscle-derived stem cells and the critical role of BMP. Biomaterials. 2014;35(25):6859-70.doi:10.1016/j.biomaterials.2014.04.113.
19. Ahmed TA, Hincke MT. Mesenchymal stem cell - based tissue engineering strategies for repair of articular cartilage. Histol Histopathol. 2014;29(6):669-89.
20. Chen W, Liu J, Manuchehrabadi N, Weir MD, Zhu Z, Xu HH. Umbilical cord and bone marrow mesenchymal stem cell seeding on macroporous calcium phosphate for bone regeneration in rat cranial defects. Biomaterials. 2013;34(38):9917-25. doi:10.1016/j.biomaterials.2013.09.002.
21. Peng L, Jia Z, Yin X, Zhang X, Liu Y, Chen P, et al. Comparative analysis of mesenchymal stem cells from bone marrow, cartilage, and adipose tissue. Stem cells and development. 2008;17(4):761-73. doi:10.1089/scd.2007.0217.
22. Rappold I, Ziegler BL, Kohler I, Marchetto S, Rosnet O, Birnbaum D, et al. Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase. Blood. 1997;90(1):111-25.
23. Simmons PJ, Przepiorka D, Thomas ED, Torok-Storb B. Host origin of marrow stromal cells following allogeneic bone marrow transplantation. Nature. 1987;328(6129):429-32. doi:10.1038/328429a0.
24. Gupta PK, Chullikana A, Parakh R, Desai S, Das A, Gottipamula S, et al. A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia. J Transl Med. 2013;11:143. doi:10.1186/1479-5876-11-143.
25. Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell. 2008;2(4):313-9. doi:10.1016/j.stem.2008.03.002.
26. Katz AJ, Tholpady A, Tholpady SS, Shang H, Ogle RC. Cell surface and transcriptional characterization of human adipose-derived adherent stromal (hADAS) cells. Stem Cells. 2005;23(3):412-23. doi:10.1634/stemcells.2004-0021.
27. Nakagami H, Morishita R, Maeda K, Kikuchi Y, Ogihara T, Kaneda Y. Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy. J Atheroscler Thromb. 2006;13(2):77-81.
28. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006;24(5):1294-301. doi:10.1634/stemcells.2005-0342.
29. Hjortholm N, Jaddini E, Halaburda K, Snarski E. Strategies of pain reduction during the bone marrow biopsy. Annals of hematology. 2013;92(2):145-9. doi:10.1007/s00277-012-1641-9.
30. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13(12):4279-95. doi:10.1091/mbc.E02-02-0105.
31. De Ugarte DA, Morizono K, Elbarbary A, Alfonso Z, Zuk PA, Zhu M, et al. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs. 2003;174(3):101-9.
32. Schaffler A, Buchler C. Concise review: adipose tissue-derived stromal cells-basic and clinical implications for novel cell-based therapies. Stem Cells. 2007;25(4):818-27. doi:10.1634/stemcells.2006-0589.
33. Amos PJ, Kapur SK, Stapor PC, Shang H, Bekiranov S, Khurgel M, et al. Human adipose-derived stromal cells accelerate diabetic wound healing: impact of cell formulation and delivery. Tissue Eng Part A. 2010;16(5):1595-606. doi:10.1089/ten.TEA.2009.0616.
34. Park JY, Jeon HJ, Kim TY, Lee KY, Park K, Lee ES, et al. Comparative analysis of mesenchymal stem cell surface marker expression for human dental mesenchymal stem cells. Regen Med. 2013;8(4):453-66. doi:10.2217/rme.13.23.
35. Strioga M, Viswanathan S, Darinskas A, Slaby O, Michalek J. Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. Stem cells and development.2012;21(14):2724-52. doi:10.1089/scd.2011.0722.
36. Casteilla L, Planat-Benard V, Laharrague P, Cousin B. Adipose-derived stromal cells: Their identity and uses in clinical trials, an update. World J Stem Cells. 2011;3(4):25-33. doi:10.4252/wjsc.v3.i4.25.
37. Valenzuela CD, Allori AC, Reformat DD, Sailon AM, Allen RJ, Jr., Davidson EH, et al. Characterization of adipose-derived mesenchymal stem cell combinations for vascularized bone engineering. Tissue Eng Part A. 2013;19(11-12):1373-85. doi:10.1089/ten.TEA.2012.0323.
38. Diederichs S, Shine KM, Tuan RS. The promise and challenges of stem cell-based therapies for skeletal diseases: stem cell applications in skeletal medicine: potential, cell sources and characteristics, and challenges of clinical translation. Bioessays. 2013;35(3):220-30. doi:10.1002/bies.201200068.
39. Rothrauff BB, Tuan RS. Cellular therapy in bone-tendon interface regeneration. Organogenesis. 2014;10(1):13-28. doi:10.4161/org.27404.
40. Tuan RS. Regenerative medicine in 2012: the coming of age of musculoskeletal tissue engineering. Nat Rev Rheumatol. 2013;9(2):74-6. doi:10.1038/nrrheum.2012.235.
41. Sakaguchi Y, Sekiya I, Yagishita K, Ichinose S, Shinomiya K, Muneta T. Suspended cells from trabecular bone by collagenase digestion become virtually identical to mesenchymal stem cells obtained from marrow aspirates. Blood. 2004;104(9):2728-35. doi:10.1182/blood-2003-12-4452.
42. Tuli R, Seghatoleslami MR, Tuli S, Wang ML, Hozack WJ, Manner PA, et al. A simple, high-yield method for obtaining multipotential mesenchymal progenitor cells from trabecular bone. Mol Biotechnol. 2003;23(1):37-49. doi:10.1385/MB:23:1:37.
43. Tuli R, Tuli S, Nandi S, Wang ML, Alexander PG, Haleem-Smith H et al. Characterization of multipotential mesenchymal progenitor cells derived from human trabecular bone. Stem Cells. 2003;21(6):681-93. doi:10.1634/stemcells.21-6-681.
44. Zhu H, Guo ZK, Jiang XX, Li H, Wang XY, Yao HY, et al. A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone. Nat Protoc. 2010;5(3):550-60. doi:10.1038/nprot.2009.238.
45. Short BJ, Brouard N, Simmons PJ. Prospective isolation of mesenchymal stem cells from mouse compact bone. Methods Mol Biol. 2009;482:259-68. doi:10.1007/978-1-59745-060-7-16.
46. Corradetti B, Correani A, Romaldini A, Marini MG, Bizzaro D, Perrini C, et al. Amniotic membrane-derived mesenchymal cells and their conditioned media: potential candidates for uterine regenerative therapy in the horse. PloS one. 2014;9(10):e111324. doi:10.1371/journal.pone.0111324.
47. Lange-Consiglio A, Tassan S, Corradetti B, Meucci A, Perego R, Bizzaro D, et al. Investigating the efficacy of amnion-derived compared with bone marrow-derived mesenchymal stromal cells in equine tendon and ligament injuries. Cytotherapy. 2013;15(8):1011-20. doi:10.1016/j.jcyt.2013.03.002.
48. Corradetti B, Lange-Consiglio A, Barucca M, Cremonesi F, Bizzaro D. Size-sieved subpopulations of mesenchymal stem cells from intervascular and perivascular equine umbilical cord matrix. Cell proliferation. 2011;44(4):330-42. doi:10.1111/j.1365-2184.2011.00759.x.
49. Golub EE, Boesze-Battaglia K. The role of alkaline phosphatase in mineralization. Current Opinion in Orthopaedics. 2007;18(5):444-8.
50. Veronesi F, Giavaresi G, Tschon M, Borsari V, Nicoli Aldini N, Fini M. Clinical use of bone marrow, bone marrow concentrate, and expanded bone marrow mesenchymal stem cells in cartilage disease. Stem cells and development. 2013;22(2):181-92. doi:10.1089/scd.2012.0373.
51. Myeroff C, Archdeacon M. Autogenous bone graft: donor sites and techniques. The Journal of bone and joint surgery American volume. 2011;93(23):2227-36. doi:10.2106/JBJS.J.01513.
52. De Ugarte DA, Alfonso Z, Zuk PA, Elbarbary A, Zhu M, Ashjian P, et al. Differential expression of stem cell mobilization-associated molecules on multi-lineage cells from adipose tissue and bone marrow. Immunology letters. 2003;89(2-3):267-70.
53. Park SH, Sim WY, Min BH, Yang SS, Khademhosseini A, Kaplan DL. Chip-based comparison of the osteogenesis of human bone marrow- and adipose tissue-derived mesenchymal stem cells under mechanical stimulation. PloS one. 2012;7(9):e46689. doi:10.1371/journal.pone.0046689.
54. Kang BJ, Ryu HH, Park SS, Koyama Y, Kikuchi M, Woo HM, et al. Comparing the osteogenic potential of canine mesenchymal stem cells derived from adipose tissues, bone marrow, umbilical cord blood, and Wharton's jelly for treating bone defects. Journal of veterinary science. 2012;13(3):299-310.
55. Liu TM, Martina M, Hutmacher DW, Hui JH, Lee EH, Lim B. Identification of common pathways mediating differentiation of bone marrow- and adipose tissue-derived human mesenchymal stem cells into three mesenchymal lineages. Stem Cells. 2007;25(3):750-60. doi:10.1634/stemcells.2006-0394.
56. Shafiee A, Seyedjafari E, Soleimani M, Ahmadbeigi N, Dinarvand P, Ghaemi N. A comparison between osteogenic differentiation of human unrestricted somatic stem cells and mesenchymal stem cells from bone marrow and adipose tissue. Biotechnology letters. 2011;33(6):1257-64. doi:10.1007/s10529-011-0541-8.
57. Honczarenko M, Le Y, Swierkowski M, Ghiran I, Glodek AM, Silberstein LE. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells. 2006;24(4):1030-41. doi:10.1634/stemcells.2005-0319.
58. Tydings JD, Martino LJ, Kircher M, Alfred R, Lozman J. The osteoinductive potential of intramedullary canal bone reamings. Current surgery. 1986;43(2):121-4.
59. Kuci S, Kuci Z, Kreyenberg H, Deak E, Putsch K, Huenecke S, et al. CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties. Haematologica. 2010;95(4):651-9. doi:10.3324/haematol.2009.015065.
60. Jones EA, English A, Kinsey SE, Straszynski L, Emery P, Ponchel F, et al. Optimization of a flow cytometry-based protocol for detection and phenotypic characterization of multipotent mesenchymal stromal cells from human bone marrow. Cytometry Part B, Clinical cytometry. 2006;70(6):391-9.doi:10.1002/cyto.b.20118.
61. Komori T. Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell and tissue research. 2010;339(1):189-95. doi:10.1007/s00441-009-0832-8.
62. McKee MD, Pedraza CE, Kaartinen MT. Osteopontin and wound healing in bone. Cells Tissues Organs. 2011;194(2-4):313-9. doi:10.1159/000324244. 3
63. Inman CK, Shore P. The osteoblast transcription factor Runx2 is expressed in mammary epithelial cells and mediates osteopontin expression. The Journal of biological chemistry. 2003;278(49):48684-9. doi:10.1074/jbc.M308001200.
64. Reinecke H, Murry CE. Cell grafting for cardiac repair. Methods Mol Biol. 2003;219:97-112.
65. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 2002;105(1):93-8.
66. Liu Y, Ma T. Metabolic regulation of mesenchymal stem cell in expansion and therapeutic application. Biotechnology progress. 2015;31(2):468-81.doi:10.1002/btpr.2034.
67. Zhang M, Methot D, Poppa V, Fujio Y, Walsh K, Murry CE. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. Journal of molecular and cellular cardiology. 2001;33(5):907-21. doi:10.1006/jmcc.2001.1367.
68. Palomaki S, Pietila M, Laitinen S, Pesala J, Sormunen R, Lehenkari P, et al. HIF-1alpha is upregulated in human mesenchymal stem cells. Stem Cells. 2013;31(9):1902-9. doi:10.1002/stem.1435.
69. Liu L, Yu Q, Lin J, Lai X, Cao W, Du K, et al. Hypoxia-inducible factor-1alpha is essential for hypoxia-induced mesenchymal stem cell mobilization into the peripheral blood. Stem Cells Dev. 2011;20(11):1961-71. doi:10.1089/scd.2010.0453.
70. Rocabado M. The importance of soft tissue mechanics in stability and instability of the cervical spine: a functional diagnosis for treatment planning. Cranio : the journal of craniomandibular practice. 1987;5(2):130-8.
71. Rundell SA, Guerin HL, Auerbach JD, Kurtz SM. Effect of nucleus replacement device properties on lumbar spine mechanics. Spine. 2009;34(19):2022-32. doi:10.1097/BRS.0b013e3181af1d5a.
72. Corradetti B, Taraballi F, Powell S, Sung D, Minardi S, Ferrari M, et al. Osteoprogenitor cells from bone marrow and cortical bone: understanding how the environment affects their fate. Stem Cells Dev. 2015;24(9):1112-23.doi:10.1089/scd.2014.0351.
73. Al-Nbaheen M, Vishnubalaji R, Ali D, Bouslimi A, Al-Jassir F, Megges M, et al. Human stromal (mesenchymal) stem cells from bone marrow, adipose tissue and skin exhibit differences in molecular phenotype and differentiation potential. Stem cell reviews. 2013;9(1):32-43. doi:10.1007/s12015-012-9365-8.